Long-Term Follow-Up of Ranimizumab for RVO Patients

This research presentation provides a robust analysis of Ranimizumab's role in treating retinal vein occlusion (RVO), focusing on insights from the HORIZON and RETAIN trials. It explores macular oedema resolution, visual outcomes, and the comparative needs of central and branch RVO patients. Emphasis is placed on the implications for clinical practice, including personalised treatment plans and Ranimizumab's safety profile. The analysis also identifies gaps in current research, highlighting...